Identification and characte... - Researchers

Identification and characterization of a novel SNAT2 (SLC38A2) inhibitor reveals synergy with glucose transport inhibition in cancer cells

Citation

Gauthier-Coles, G, Broer, A, McLeod, M et al. 2022, 'Identification and characterization of a novel SNAT2 (SLC38A2) inhibitor reveals synergy with glucose transport inhibition in cancer cells', Frontiers in Pharmacology, vol. 13.

Year

2022

ANU Authors

Mr Gregory Gauthier-Coles
Professor Malcolm McLeod
Associate Professor Amee George
Professor Ross Hannan
Professor Stefan Broer

Updated: 20 July 2024 / Responsible Officer: Director (Research Services Division) / Page Contact: Researchers